Real|world treatment patterns and outcomes in relapsed/refractory ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

The most common subsequent treatments were triplet combinations (41.6% of patients); daratumumab/pomalidomide/dexamethasone was the most common ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

The most common subsequent treatments were triplet combinations (41.6% of patients); daratumumab/pomalidomide/dexamethasone was the most common ...

Real-world assessment of treatment patterns and outcomes in ...

Lenalidomide-refractory patients, among those relapsed after LOT-1, were 26% and 64.5% respectively, in patients starting therapy before 2019 ...

Real-World Treatment Patterns and Patient Outcomes in Relapsed ...

In this real-world evaluation of the treatment patterns and outcomes among patients in post-RRHL evidence setting, BV was administered more ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...

The treatment landscape for relapsed/refractory multiple myeloma (RRMM) has evolved over the last decade, and several therapeutic options are now available in ...

Current real-world treatment patterns and outcomes in patients with ...

Background: Limited real-world data exist on treatments for relapsed/refractory multiple myeloma (RRMM) since the recent approval of new agents.

Recent real-world treatment patterns and outcomes in US patients ...

In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1–3 therapy lines, newer agents demonstrated improved outcomes versus older ...

Evolving treatment patterns and improved outcomes in relapsed ...

Clinical characteristics, 2 L treatment details, and outcomes were compared between patients who received 2 L treatment between 2003–2009 (Era 1) ...

REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN ...

5%) being the most utilized regimens in 2L and 3L, respectively (Fig. 1). In total, 53.1% were LEN-retreated and 30.8% were LEN-refractory. The median ( ...

Assessment of real-world treatment patterns and outcomes in ...

The survey collected physicians' opinions on typical treatment patterns and outcomes of RRMM patients in the relapse/refractory setting (following disease ...

results from the international SCHOLAR-5 study | Haematologica

The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom ...

Real‐World Treatment Patterns, Outcomes, and Healthcare ...

From first relapse, patients were assessed on second-/third-line treatments, progression-free survival (PFS), overall survival (OS), and ...

KarMMa-RW: A study of real-world treatment patterns in heavily ...

KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with relapsed and refractory multiple myeloma (RRMM) and ...

Real-world treatment patterns in relapsed/refractory multiple myeloma

Introduction: Real-world evidence on later line treatment of relapsed/refractory multiple myeloma (RRMM) is sparse. We evaluated clinical outcomes among ...

Evolving Treatment Patterns Lead to Improved Outcomes ... - OncLive

Patients who received second-line treatment for relapsed/refractory MCL between 2003 to 2009 (Era 1; n = 61), 2010 to 2014 (Era 2; n = 73), and ...

3242 Real-World Treatment Patterns and Outcomes of Proteasome ...

3242 Real-World Treatment Patterns and Outcomes of Proteasome Inhibitor ... Relapsed/Refractory Multiple Myeloma (RRMM) Engaged in Routine Care in the ...

Refractory Multiple Myeloma with At Least Two Prior Therapies in ...

Real-World Treatment Patterns and Outcomes in Patients with Relapsed/ ... (refractory) and are known as relapsed/refractory multiple myeloma (RRMM) ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

Request PDF | Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database | In ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH AT LEAST ONE PRIOR THERAPY IN BRAZIL. A Maiolinoa , M ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

Real-world treatment patterns and outcomes in relapsed/refractory multiple myeloma (1-3 prior lines): Flatiron database ... Authors: Binod Dhakal; Hermann Einsele ...